Detailed TOC of Global Hemoglobin Testing Market 2016-2020
PART 01: Executive summary• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Invasive method
• Non-invasive method
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Global hemoglobin testing equipment market
• Global hemoglobin testing reagents and consumables market
PART 07: Market segmentation by technology
• Chromatography
• Immunoassay
• Other
PART 08: Market segmentation by end-user
• Laboratories
• Hospitals
• Research centers
PART 09: Geographical segmentation
• Hemoglobin testing market in Americas
• Reimbursement by Medicare in US
• Hemoglobin testing market in EMEA
• Hemoglobin testing market in APAC
PART 10: Market drivers
• Increasing incidence of diabetes and popularity of HbA1c tests
• Favorable reimbursement of hemoglobin testing
• Development and launch of novel hemoglobin testing devices
PART 11: Impact of drivers
PART 12: Market challenges
• High cost and maintenance of hemoglobin testing
• Stringent regulatory issues
• Threat of substitute products
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Shift from centralized laboratory to POCT
• Increased mergers and acquisition (M&A)
• Direct-to-consumer testing
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendor profiles
• Abbott Diagnostics
• Alere
• Danaher
• EKF Diagnostics Holdings
• Roche Diagnostics
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Types of hemoglobin testing methods
Exhibit 03: Global hemoglobin testing market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global hemoglobin testing market segmentation based on product
Exhibit 06: Global hemoglobin testing market segmentation based on product 2015
Exhibit 07: Global hemoglobin testing market segmentation based on product 2020
Exhibit 08: Global hemoglobin testing equipment market 2015
Exhibit 09: Global hemoglobin testing equipment market 2020
Exhibit 10: Global hemoglobin testing equipment market 2015-2020 ($ millions)
Exhibit 11: Global laboratory testing market 2015-2020 ($ millions)
Exhibit 12: Global POCT equipment market 2015-2020 ($ millions)
Exhibit 13: Global hemoglobin testing reagent and consumables market 2015-2020 ($ billions)
Exhibit 14: Segmentation of global hemoglobin testing market by product
Exhibit 15: Segmentation of global hemoglobin testing market by product ($ millions)
Exhibit 16: Segmentation of global hemoglobin testing market by technology 2015
Exhibit 17: Segmentation of global hemoglobin testing market by end-user 2015
Exhibit 18: Segmentation of global hemoglobin testing market by geography 2015
Exhibit 19: Segmentation of global hemoglobin testing market by geography 2020
Exhibit 20: Hemoglobinin testing market in Americas 2015-2020 ($ millions)
Exhibit 21: Selected laboratory service with national limitation amount (NLA) provided by Medicare
Exhibit 22: Estimation of few diseases in US
Exhibit 23: Hemoglobin testing market in EMEA 2015-2020 ($ millions)
Exhibit 24: Hemoglobin testing market in APAC 2015-2020 ($ millions)
Exhibit 25: Segmentation of global hemoglobin testing market by geography
Exhibit 26: Segmentation of global hemoglobin testing market by geography ($ millions)
Exhibit 27: Impact of drivers
Exhibit 28: Impact of drivers and challenges
Exhibit 29: Abbott Diagnostics: Key takeaways
Exhibit 30: Alere: Business segmentation by revenue 2014
Exhibit 31: Alere: Cardiometabolic division revenue and YoY growth rate 2012-2014 ($ millions)
Exhibit 32: Alere: Key takeaways
Exhibit 33: Danaher: Key takeaways
Exhibit 34: EKF Diagnostics: Business segmentation by revenue 2014
Exhibit 35: EKF Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 36: EKF Diagnostics Holdings: Key takeaways
Exhibit 37: Roche Diagnostics: Business segmentation by revenue 2015
Exhibit 38: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2015
Exhibit 39: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 40: Roche Diagnostics: Diabetes care - YoY revenue and growth rate ($ billions)
Exhibit 41: Roche Diagnostics: Key takeaways